Veracyte, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US92337F1075
USD
47.22
1.07 (2.32%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
150.32
139.07
140.64
131.87
130.16
114.47
118.63
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
150.32
139.07
140.64
131.87
130.16
114.47
118.63
Raw Material Cost
42.19
38.49
39.28
42.52
42.41
37.07
42.16
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
64.70
61.56
54.43
53.39
55.60
54.41
50.20
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
54.81
49.64
54.56
50.71
57.61
59.16
46.59
Other Expenses
-3.53
-3.45
-3.36
-3.79
-3.98
-3.71
-3.14
Total Expenditure (Excl Depreciation)
126.44
115.22
114.70
108.76
115.85
113.52
107.58
Operating Profit (PBDIT) excl Other Income
23.900000000000002
23.799999999999997
25.9
23.1
14.299999999999999
1
11.100000000000001
Other Income
3.24
2.75
3.44
-4.06
5.52
4.52
-0.73
Operating Profit (PBDIT)
31.96
32.02
34.68
24.32
25.32
10.84
16.57
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
-0.60
3.38
11.26
-0.17
-18.58
1.95
-6.88
Gross Profit (PBDT)
108.13
100.58
101.35
89.36
87.75
77.40
76.48
Depreciation
4.84
5.43
5.30
5.27
5.49
5.36
6.25
Profit Before Tax
26.52
29.97
40.63
18.89
1.25
7.43
3.44
Tax
1.03
1.27
-0.52
-0.25
2.23
0.38
-1.67
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
25.49
28.71
41.15
19.14
-0.98
7.05
5.11
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
25.49
28.71
41.15
19.14
-0.98
7.05
5.11
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
25.49
28.71
41.15
19.14
-0.98
7.05
5.11
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,388.40
1,344.41
1,309.58
1,257.67
1,221.06
1,194.94
1,175.97
Earnings per share (EPS)
0.31
0.35
0.51
0.24
-0.01
0.09
0.06
Diluted Earnings per share
0.31
0.35
0.51
0.24
-0.01
0.09
0.06
Operating Profit Margin (Excl OI)
15.89%
17.15%
18.44%
17.53%
11.0%
0.83%
9.32%
Gross Profit Margin
20.86%
25.46%
32.66%
18.32%
5.18%
11.17%
8.17%
PAT Margin
16.96%
20.64%
29.26%
14.51%
-0.75%
6.16%
4.31%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2026 is 15.44% vs 13.81% in Jun 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2026 is 2,650.00% vs -117.54% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is 44.95% vs 90.38% in Jun 2025

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Compare Quarterly Results Of Veracyte, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
150.32
183.58
-33.26
-18.12%
Other Operating Income
0.00
0.00
0.00
Total Operating income
150.32
183.58
-33.26
-18.12%
Raw Material Cost
42.19
41.11
1.08
2.63%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
64.70
0.00
64.70
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
1.89
-1.89
-100.00%
Selling and Distribution Expenses
54.81
101.59
-46.78
-46.05%
Other Expenses
-3.53
4.96
-8.49
-171.17%
Total Expenditure (Excl Depreciation)
126.44
194.15
-67.71
-34.88%
Operating Profit (PBDIT) excl Other Income
23.88
-10.56
34.44
326.14%
Other Income
3.24
0.00
3.24
Operating Profit (PBDIT)
31.96
-6.25
38.21
611.36%
Interest
0.00
1.89
-1.89
-100.00%
Exceptional Items
-0.60
0.00
-0.60
Gross Profit (PBDT)
108.13
142.48
-34.35
-24.11%
Depreciation
4.84
4.31
0.53
12.30%
Profit Before Tax
26.52
-12.45
38.97
313.01%
Tax
1.03
3.21
-2.18
-67.91%
Provisions and contingencies
0
0
0.00
Profit After Tax
25.49
-15.66
41.15
262.77%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
25.49
-15.66
41.15
262.77%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
25.49
-15.66
41.15
262.77%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,388.40
338.09
1,050.31
310.66%
Earnings per share (EPS)
0.31
-0.14
0.45
321.43%
Diluted Earnings per share
0.31
-0.14
0.45
321.43%
Operating Profit Margin (Excl OI)
15.89%
-5.75%
0.00
21.64%
Gross Profit Margin
20.86%
-4.44%
0.00
25.30%
PAT Margin
16.96%
-8.53%
0.00
25.49%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 15.03 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 8.05% vs -1.07% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 15.44% vs 13.81% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 2.55 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -11.15% vs -30.17% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 2,650.00% vs -117.54% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.87 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -2.05% vs -6.09% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 44.95% vs 90.38% in Jun 2025

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.89%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025